| Bioactivity | AM6545 is a peripherally active, cannabinoid receptor antagonist with limited brain penetration. AM6545 binds to CB1 and CB2 receptors with Kis of 1.7 nM and 523 nM, respectively. AM6545 is a neutral antagonist. AM6545 can be used for the research of obesity and its complications[1]. |
| Name | AM6545 |
| CAS | 1245626-05-4 |
| Formula | C26H23Cl2N5O3S |
| Molar Mass | 556.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. N L Cluny, et al. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol. 2010 Oct;161(3):629-42. |
AM6545
CAS: 1245626-05-4 F: C26H23Cl2N5O3S W: 556.46
AM6545 is a peripherally active, cannabinoid receptor antagonist with limited brain penetration. AM6545 binds to CB1 and
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.